| Whois | Domain Name: zentase.us
Registry Domain ID: D12046021-US
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: whois.godaddy.com
Updated Date: 2023-03-06T15:05:43Z
Creation Date: 2007-03-01T20:05:59Z
Registry Expiry Date: 2024-02-28T23:59:59Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: +1.4806242505
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Registry Registrant ID: C33603D12201E4D7EAAC54397175720EB-NSR
Registrant Name: Michel Arsenault
Registrant Organization: Adare Pharmaceuticals
Registrant Street: 597 Boul. Laurier
Registrant Street:
Registrant Street:
Registrant City: Saint-Hilaire
Registrant State/Province: Quebec
Registrant Postal Code: J3H 6C4
Registrant Country: ca
Registrant Phone: +1.467260033
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: licenses@adarepharma.com
Registrant Application Purpose: P1
Registrant Nexus Category: C21
Registry Admin ID: C606FEAA3D9B2471A97873B9EEAAC4756-NSR
Admin Name: Michel Arsenault
Admin Organization: Adare Pharmaceuticals
Admin Street: 597 Boul. Laurier
Admin Street:
Admin Street:
Admin City: Saint-Hilaire
Admin State/Province: Quebec
Admin Postal Code: J3H 6C4
Admin Country: ca
Admin Phone: +1.467260033
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: licenses@adarepharma.com
Admin Application Purpose: P1
Admin Nexus Category: C21
Registry Tech ID: C5B2CDD5652054CC5965FA0702E723724-NSR
Tech Name: Michel Arsenault
Tech Organization: Adare Pharmaceuticals
Tech Street: 597 Boul. Laurier
Tech Street:
Tech Street:
Tech City: Saint-Hilaire
Tech State/Province: Quebec
Tech Postal Code: J3H 6C4
Tech Country: ca
Tech Phone: +1.467260033
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: licenses@adarepharma.com
Tech Application Purpose: P1
Tech Nexus Category: C21
Name Server: ns15.worldnic.com
Name Server: ns16.worldnic.com
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2024-01-08T10:55:00Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
.US WHOIS Complaint Tool - http://www.whoiscomplaints.us
Advanced WHOIS Instructions - http://whois.us/help.html
Registry Services, LLC, the Registry Administrator for .US, has collected this information for the WHOIS database through a
.US-Accredited Registrar. This information is provided to you for informational purposes only and is designed to assist
persons in determining contents of a domain name registration record in the registry database.
Registry Services, LLC makes this information available to you "as is" and does not guarantee its accuracy. By submitting a
WHOIS query, you agree that you will use this data only for lawful purposes and that, under no circumstances will you use
this data:
(1) to allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via
direct mail, electronic mail, or by telephone;
(2) in contravention of any applicable data and privacy protection laws; or
(3) to enable high volume, automated, electronic processes that apply to the registry (or its systems).
Compilation, repackaging, dissemination, or other use of the WHOIS database in its entirety, or of a substantial portion
thereof, is not allowed without our prior written permission.
We reserve the right to modify or change these conditions at any time without prior or subsequent notification of any kind.
By executing this query, in any manner whatsoever, you agree to abide by these terms. NOTE: FAILURE TO LOCATE A RECORD IN THE
WHOIS DATABASE IS NOT INDICATIVE OF THE AVAILABILITY OF A DOMAIN NAME. All domain names are subject to certain additional
domain name registration rules. For details, please visit our site at www.whois.us. |
|---|